- Home
- ARMP vs RFIL Comparison
ARMP vs RFIL Comparison
Compare ARMP & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARMP | RFIL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 383.7M | 99.5M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ARMP | RFIL |
|---|---|---|
| Price | $9.75 | $13.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $15.00 | $9.25 |
| AVG Volume (30 Days) | 40.2K | ★ 228.5K |
| Earning Date | 01-01-0001 | 06-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 53.40 | ★ 101.59 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $55,325,000.00 |
| Revenue This Year | N/A | $7.07 |
| Revenue Next Year | N/A | $5.72 |
| P/E Ratio | ★ N/A | $1,203.00 |
| Revenue Growth | N/A | ★ 10.22 |
| 52 Week Low | $0.90 | $3.39 |
| 52 Week High | $13.75 | $13.09 |
Technical Indicators
Market Signals| Indicator | ARMP | RFIL |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 61.97 |
| Support Level | $5.14 | $6.32 |
| Resistance Level | $12.11 | N/A |
| Average True Range (ATR) | 0.96 | 1.29 |
| MACD | -0.27 | 0.03 |
| Stochastic Oscillator | 17.65 | 87.37 |
Price Performance
Historical ComparisonAbout ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.